US Patent Issued to Cedars-Sinai Medical Center, Children's Hospital Medical Center on Sept. 16 for "Use of FGFR inhibitors for treatment of idiopathic short stature" (California, Ohio Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,947, issued on Sept. 16, was assigned to Cedars-Sinai Medical Center (Los Angeles) and Children's Hospital Medical Center (Cincinnati).

"Use of FGFR inhibitors for treatment of idiopathic short stature" was invented by Moise Danielpour (Los Angeles), Fataneh Majlessipour (Los Angeles) and Vivian Hwa (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes methods for treating idiopathic short stature. Described herein are also methods of increasing a subject's height. The methods involve administering an effective amount of a pan FGFR inhibitor or a selective FGFR inhibitor to the subject. An example of an FGRF inh...